1Stratton IM,Cull CA,Adler AI,et al.Additive effects ofglycaemia and blood pressure exposure on risk of complicationsin type 2diabetes:aprospective observational study(UKPDS75)[J].Diabetolola,2006,49(8):1761-1769.
5Fong D S, Barton F B, Bresniek G H. Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15. Am J Ophthalmol, 1999, 128: 612-617.
6Barton F B, Fong D S, Knatterud G L, et al. Classification of Farnsworth-Munsell 100 hue test results in the early treatment diabetic retinopathy study. Am J Ophthalmol, 2004, 138.119-124.
7Johnson C A, Brandt J D, Khong A M, et al. Short- wavelength automated perimetry in low-, medium-, and high- risk ocular hypertensive eyes. Initial baseline results. Arch Ophthalmol, 1995, 113: 70-76.
8Demirel S, Johnson C A. Short wavelength automated perimetry (SWAP) in ophthalmic practice. J Am Optom Assoc, 1996, 67: 451-456.
9Racette L, Sample P A. Short-wavelength automated perimetry. OphthalmolClin North Am, 2003, 16.227-236,.
10Xie XW, Xu L, Wang YX, et al. Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefes Arch Clin Exp Ophthalmol, 2008, 246: 1519-1526.
